Cytarabine Suspended Phase 3 Trials for Acute Lymphoblastic Leukaemias (ALL) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00991744Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)